Navigation Links
COX-2 inhibitors Lessen Breast Cancer Risk

Selective usage of COX-2 inhibitors like rofecoxib (Vioxx) and celecoxib (Celebrex) reduces breast cancer risk by 71%, according to a study. The Ohio State University College of Medicine and Public Health's Randall Harris led the // research which came to this conclusion. The nonsteroidal anti-inflammatory drugs (NSAIDs) play a prominent role in the prevention of breast cancer.

The researchers observed that while daily use of selective COX-2 inhibitors was associated with a 71% reduction in the risk of breast cancer, non-selective COX-2 inhibitors, such as aspirin and ibuprofen, also reduced the risk of breast cancer. The study's results show that selective COX-2 inhibitors, as a group, were associated with a significantly reduced risk of breast cancer when taken daily for at least two years.

While a daily dose of 200 mg celecoxib reduced the risk of breast cancer by 83%, a daily dose of 25 mg rofecoxib reduced the risk of breast cancer by 64%. Regular use of non-selective COX-2 inhibitors like aspirin (325 mg), ibuprofen (200mg) and naproxen (250 mg) also significantly reduced the risk of breast cancer, but less so than the regular intake of selective COX-2 inhibitors. It was found that Ibuprofen and aspirin significantly decreased the risk of developing breast cancer when taken at least every other day for at least five years.

However, the researchers also found that regular intake of acetaminophen, an analgesic lacking COX-2 activity, had no effect on the risk of breast cancer. The study is published in the open access journal BMC Cancer.

Edited (ANI)
'"/>




Page: 1

Related medicine news :

1. Green Tea and COX-2 Inhibitors Combine to Slow Growth of Prostate Cancer
2. Phase 3 trials of two multi-kinase inhibitors against cancer
3. Lessening operation and recovery time
4. Physical Exertion Can Lessen Depression
5. Risk Of Stroke Can Be Lessened By Proper Diet
6. Fatigue After Liver Transplantation Does Not Lessen With Time
7. Vulnerability to Ear Infections Lessened by Breast Feeding
8. A Discovery That may Lessen a Health Disparity
9. Consensus on "Combination Therapy" for Breast Cancer
10. Breast cancer treatment to be determined by gene test
11. Breast Feeding prevents obesity later on in life
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2016)... ... May 24, 2016 , ... Women's ... , Roberta Jordan is a Certified Nurse Midwife who was born and raised ... then went on to complete her masters degree from the University of Mexico. ...
(Date:5/24/2016)... ... 24, 2016 , ... Educational opportunities, and therefore life chances, ... communities providing richer opportunities. Recognizing the key role of housing in this system, ... school choice policies; (c) school desegregation policies; (d) wealth-focused policies; and (e) housing-focused ...
(Date:5/24/2016)... ... 24, 2016 , ... Regenerative Medicine is being transformed by ongoing research and ... protocols and patient results as have been achieved with Okyanos Cell Therapy ... of care for patients worldwide. , As the Medical Advisory Chairman at Okyanos, Eric ...
(Date:5/24/2016)... ... 2016 , ... Backed by decades of experience, Metroloji Okulu ... the best suited solution to meet regulatory requirements. Their professional staff also performs ... Istanbul. , Metroloji Okulu specializes in MadgeTech’s line of medical and pharmaceutical ...
(Date:5/24/2016)... ... May 24, 2016 , ... American Gene Technologies ... to its board of directors. Otterstatter is co-founder, president and CEO of ... technological innovations that lead to broad-based healthcare solutions. , “Jon knows how to ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... , May 24, 2016 ... beide primären Endpunkte und demonstriert ... in ‚ausgezeichneter plus guter , ...    ,      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ... heute neue positive Daten von der MORA-Studie der ...
(Date:5/24/2016)... LAWRENCE, Mass. , May 24, 2016  NxStage ... medical technology company focused on advancing renal care, today ... Officer, plans to participate in the following schedule of ... will be made available at http://ir.nxstage.com/ . ... Jefferies Healthcare Conference NY, NY           Friday, ...
(Date:5/24/2016)... , May 24, 2016 ... de doble terapia del mundo, introduce catéteres para ... OrbusNeich, una compañía global especializada en ... vidas, ha expandido su cartera incluyendo productos para ... JADE™ y Scoreflex™ PTA son los dispositivos de ...
Breaking Medicine Technology: